LANSING, Mich., March 12, 2013 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the “Company” or “Kraig”), the leading developer of advanced spider silk based fibers, announced today that the Company has received an invitation from the council office of a foreign country to visit that country. The purpose of the invitation is to meet with governmental officials to discuss and explore the potential to produce the Company’s recombinant spider silk there.
“It is a great honor for Kraig to receive this diplomatic invitation,” said Company founder and CEO, Kim Thompson. “It also represents a unique opportunity. We have accepted the invitation to visit a potential production location and to meet with officials to discuss the business opportunities presented.”
The Company’s CEO anticipates traveling to that country and exploring the production possibilities within the next three weeks.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
CONTACT:
Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com